iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

JB Chemicals gets USFDA approval for generic drug marketing

24 Aug 2023 , 10:05 AM

JB Chemicals & Pharmaceuticals announced on Wednesday that it has gained approval from the US Food and Drug Administration to offer a generic medicine used to treat mood disorders in the US market.

According to a regulatory filing, JB Chemicals & Pharmaceuticals received USFDA approval to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg.

The company’s product is a generic version of Pfizer’s Sinequan capsules, which are used to treat anxiety, depression, and other psychoneurosis-related symptoms.

According to the pharma company, the drug would be created at the company’s formulation production facility in Panoli, Gujarat.

According to IQVIA MAT data, Doxepin Hydrochloride capsules had an estimated annual sales value of USD 23.90 million in the United States.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • JB Chemicals
  • JB Chemicals News
  • JB Chemicals Updates
  • Pharma news
  • USFDA approval
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.